2025年免疫组织化学（IHC）全球市场报告

近年来，免疫组织化学 (IHC) 市场呈现强劲成长势头，市场规模从 2024 年的 25.8 亿美元成长至 2025 年的 27.6 亿美元，复合年增长率达 7.2%。这段时期的成长得益于临床应用、产业标准化、癌症研究的不断扩展、实验室自动化以及临床诊断技术的进步。

预计未来几年免疫组织化学 (IHC) 市场将快速成长，到 2029 年将达到 40.7 亿美元，复合年增长率为 10.2%。预测期内的成长主要源自于新参与企业的市场、药物开发、生物医学研究整合、诊断应用、自动化数位化。预测期内的主要趋势包括多重 IHC 技术、数位病理学整合、抗体特异性的提高、自动化和标准化以及在生物标记发现中的应用。

免疫组织化学 (IHC) 是一种利用抗体-抗原交互作用来识别组织切片中特定蛋白质或抗原的诊断技术。这种相互作用可以透过使用酶基材的显色检测或使用萤光染料的萤光检测来可视化。

免疫组织化学 (IHC) 相关的关键产品包括抗体、仪器、试剂和套件。抗体是由免疫系统产生的蛋白质，用于中和有害抗原。在 IHC 领域，抗体用于检测蛋白质或抗原的特定位置，以用于诊断目的。 IHC 的应用涵盖诊断、药物检测和其他相关领域，最终用户包括医院、诊断实验室和研究机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供免疫组织化学 (IHC) 市场统计数据，例如全球市场规模、区域份额、免疫组织化学 (IHC) 市场份额竞争对手、详细的免疫组织化学 (IHC) 细分市场、市场趋势和机会，以及您在免疫组织中取得成功所需的数据。本免疫组织化学 (IHC) 市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为10.2%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。这种影响可能会透过供应链中断直接影响美国，例如来自比利时和新加坡等主要地区的自动染色平台和抗原捕获缓衝液，这可能导致癌症生物标记分析的延迟和组织病理学检测成本的增加。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响可能会更加广泛。

由于慢性病的盛行率不断上升，免疫组织化学 (IHC) 市场预计将持续成长。慢性病是指通常可控制但无法治癒的长期疾病，包括癌症和心血管疾病等。免疫组织化学具有特异性强、检测特异性抗原的敏感度高以及快速出结果等优势，使其成为诊断这些疾病的关键。美国疾病管制与预防中心报告称，2022 年美国将有约 3,730 万人患糖尿病，占总人口的 11.3%，这凸显了免疫组织化学在应对日益加重的慢性病负担方面发挥的作用。

免疫组织化学 (IHC) 市场的成长进一步受到个人化医疗需求的推动，个人化医疗是指根据每位患者独特的基因、环境和生活方式特征，量身定制医疗决策和干预措施。免疫组织化学在其中发挥关键作用，它能够检测对肿瘤准确分类和诊断至关重要的特异性蛋白质标记物。个人化医疗联盟预测，未来将有超过 75,000 种基因检测产品和 300 多种个人化药物可用于治疗各种疾病，凸显了免疫组织化学在个人化医疗发展中的关键作用。

免疫组织化学 (IHC) 市场涵盖一抗、玻片染色系统、组织微阵列、组织处理系统、玻片扫描仪、二抗、组织染色剂、封闭血清及试剂、呈色受质、固定剂和稳定剂的销售。该市场的价值为「工厂门口」价值，即商品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 整体免疫组织化学 (IHC)：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球免疫组织化学（IHC）市场：成长率分析
• 全球免疫组织化学 (IHC) 市场表现：规模与成长，2019-2024 年
• 全球免疫组织化学 (IHC) 市场预测：规模与成长，2024-2029 年，2034 年
• 全球免疫组织化学（IHC）：总目标市场（TAM）

第六章 市场细分

• 全球免疫组织化学 (IHC) 市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 抗体
• 装置
• 试剂
• 套件
• 全球免疫组织化学 (IHC) 市场的应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 诊断
• 药物检测
• 其他的
• 全球免疫组织化学 (IHC) 市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
• 医院和诊断实验室
• 研究所
• 其他的
• 全球免疫组织化学 (IHC) 市场：抗体细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 一抗
• 二抗
• 结合抗体
• 全球免疫组织化学 (IHC) 市场：仪器细分、类型、性能和预测（2019-2024 年、2024-2029 年、2034 年）
• IHC染色系统
• 组织处理装置
• 幻灯片扫描仪
• 显微镜
• 全球免疫组织化学 (IHC) 市场：试剂细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 检测试剂
• 阻断试剂
• 镶嵌剂
• 全球免疫组织化学 (IHC) 市场：套件细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 即用型 IHC套件
• 多重 IHC套件
• 特殊套件

第七章 区域和国家分析

• 全球免疫组织化学 (IHC) 市场各地区、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
• 全球免疫组织化学 (IHC) 市场（按国家/地区划分）、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 免疫组织化学（IHC）市场：竞争格局
• 免疫组织化学（IHC）市场：公司简介
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • The Merck Group
  • Danaher Corporation
  • PerkinElmer Inc.

第31章：其他领先和创新企业

• Bio-Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• Bio SB Inc.
• Agilent Technologies Inc.
• Abcam plc
• Becton Dickinson and Company
• Takara Bio Inc.
• Biocare Medical LLC
• Bio-Genex Laboratories
• Diagnostic BioSystems Inc.
• BioVision Inc.
• PHC Holdings Corporation
• Abbott Laboratories
• Leica Biosystems
• Vector Laboratories

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

• 2029 年免疫组织化学 (IHC) 市场：提供新机会的国家
• 2029 年免疫组织化学 (IHC) 市场：细分领域带来新机会
• 免疫组织化学 (IHC) 市场，2029 年：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Immunohistochemistry (IHC) is a diagnostic technique that utilizes the interaction between antibodies and antigens to identify specific proteins and antigens within tissue sections. This interaction is visualized through chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dyes.

The main products associated with immunohistochemistry (IHC) include antibodies, equipment, reagents, and kits. Antibodies are proteins produced by the immune system to neutralize harmful antigens, and in the context of IHC, they are employed to detect the specific location of proteins or antigens for diagnostic purposes. The applications of IHC span diagnostics, drug testing, and other related areas, with end-users including hospitals, diagnostic laboratories, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The immunohistochemistry (IHC) market research report is one of a series of new reports from The Business Research Company that provides immunohistochemistry (IHC) market statistics, including immunohistochemistry (IHC) industry global market size, regional shares, competitors with a immunohistochemistry (IHC) market share, detailed immunohistochemistry (IHC) market segments, market trends and opportunities, and any further data you may need to thrive in the immunohistochemistry (IHC) industry. This immunohistochemistry (IHC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohistochemistry (ihc) market size has grown strongly in recent years. It will grow from $2.58 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to clinical adoption, industry standardization, expansion in cancer research, automation in laboratories, clinical diagnostics advancements.

The immunohistochemistry (ihc) market size is expected to see rapid growth in the next few years. It will grow to $4.07 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to market entry of new players, demand in drug development, biomedical research integration, diagnostic applications, automation and digitalization. Major trends in the forecast period include multiplex IHC techniques, digital pathology integration, enhanced antibody specificity, automation and standardization, application in biomarker discovery.

The forecast of 10.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for automated staining platforms and antigen retrieval buffers, sourced from key regions such as Belgium and Singapore, which could lead to slower cancer biomarker analysis and increased histopathology costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The immunohistochemistry (IHC) market is anticipated to witness growth due to the increasing prevalence of chronic diseases. Chronic diseases, lasting for extended periods and typically manageable but not curable, include conditions such as cancer and cardiovascular disorders. Immunohistochemistry is crucial in diagnosing these diseases, offering advantages such as specificity, sensitivity to detect specific antigens, and rapid results. In 2022, the Centers for Disease Control and Prevention reported that approximately 37.3 million people in the United States, accounting for 11.3% of the population, have diabetes, emphasizing the role of immunohistochemistry in addressing the rising burden of chronic diseases.

The growth of the immunohistochemistry (IHC) market is further driven by the increasing demand for personalized medicines. Personalized medicine tailors medical decisions and interventions based on individual patients' unique genetic, environmental, and lifestyle characteristics. Immunohistochemistry plays a significant role in this context, detecting specific protein markers crucial for accurate tumor classification and diagnosis. The Personalized Medicine Coalition projected that over 75,000 genetic testing products and 300 personalized medicines will be available for various diseases, reinforcing the pivotal role of immunohistochemistry in advancing personalized medicine.

Major players in the immunohistochemistry (IHC) market are concentrating on improving diagnostic accuracy through innovative technologies and high-quality reagents to enhance tissue analysis effectiveness in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is a cutting-edge imaging platform tailored for precise tissue analysis, enabling researchers to progress from discovery to clinical applications using high-resolution mass spectrometry techniques, especially for spatially mapping biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US-based company that develops and manufactures scientific instruments along with analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. The Neoflex MSI system addresses the demand for advancing from discovery imaging to clinical tissue research. It incorporates Bruker's 10-kHz smartbeam 3D laser, improved imaging detectors, and supports OME-TIFF file output with SCiLS Scope software.

Leading companies in the immunohistochemistry (IHC) market are prioritizing technological advancements, such as automated staining systems, to boost diagnostic accuracy and efficiency for pathologists, ultimately improving patient outcomes. The Tissue-Tek Genie represents an innovative, fully automated staining system for immunohistochemistry (IHC) and in situ hybridization (ISH), designed to deliver rapid, high-quality, and standardized results to enhance diagnostic precision in histopathology. For instance, in September 2022, Sakura Finetek, a US-based medical equipment company, launched its latest solution, Tissue-Tek Genie, an advanced staining system focused on providing optimal scoring antibodies for the best possible results for pathologists and their patients. The Tissue-Tek Genie Advanced Staining System is the first fully automated, true random access stainer for immunohistochemistry (IHC) and in situ hybridization (ISH).

In November 2022, Leica Biosystems, a Germany-based medical devices firm, acquired Cell IDx, Inc. for an undisclosed sum. This acquisition aims to enhance Leica Biosystems' multiplex immunohistochemistry (IHC) capabilities and improve cancer diagnostics by integrating its UltraPlex technology for advanced biomarker detection and tissue-based diagnostics. Cell IDx is a US-based biotechnology company specializing in multiplexed tissue profiling.

Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunohistochemistry (ihc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunohistochemistry (IHC) market consists of sales of primary antibodies, slide staining system, tissue microarrays, tissue processing systems, slide scanners secondary antibodies, histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents and stabilizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohistochemistry (IHC) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunohistochemistry (ihc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohistochemistry (ihc) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunohistochemistry (ihc) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Antibodies; Equipment; Reagents; Kits
• 2) By Applications: Diagnostics; Drug Testing; Other Applications
• 3) By End-Users: Hospitals And Diagnostic Laboratories; Research Institutes; Other End-Users
• Subsegments:
• 1) By Antibodies: Primary Antibodies; Secondary Antibodies; Conjugated Antibodies
• 2) By Equipment: IHC Staining Systems; Tissue Processors; Slide Scanners; Microscopes
• 3) By Reagents: Detection Reagents; Blocking Reagents; Mounting Media
• 4) By Kits: Pre-prepared IHC Kits; Multiplex IHC Kits; Specialty Kits
• Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; The Merck Group; Danaher Corporation; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; Bio SB Inc.; Agilent Technologies Inc.; Abcam plc; Becton Dickinson and Company; Takara Bio Inc.; Biocare Medical LLC; Bio-Genex Laboratories; Diagnostic BioSystems Inc.; BioVision Inc.; PHC Holdings Corporation; Abbott Laboratories; Leica Biosystems; Vector Laboratories; Indivumed GmbH; Qritive; Ionpath Inc.; Reveal Biosciences; Akrivis Technologies Private Limited; LifeSpan BioSciences Inc.; Enzo Life Sciences Inc.; Epitomics Inc.; GenScript Biotech; Histologix Ltd.; NeoGenomics Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunohistochemistry (IHC) Market Characteristics

3. Immunohistochemistry (IHC) Market Trends And Strategies

4. Immunohistochemistry (IHC) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunohistochemistry (IHC) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Immunohistochemistry (IHC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Immunohistochemistry (IHC) Market Growth Rate Analysis
• 5.4. Global Immunohistochemistry (IHC) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Immunohistochemistry (IHC) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Immunohistochemistry (IHC) Total Addressable Market (TAM)

6. Immunohistochemistry (IHC) Market Segmentation

• 6.1. Global Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibodies
• Equipment
• Reagents
• Kits
• 6.2. Global Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Drug Testing
• Other Applications
• 6.3. Global Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Diagnostic Laboratories
• Research Institutes
• Other End-Users
• 6.4. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Antibodies
• Secondary Antibodies
• Conjugated Antibodies
• 6.5. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• IHC Staining Systems
• Tissue Processors
• Slide Scanners
• Microscopes
• 6.6. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Detection Reagents
• Blocking Reagents
• Mounting Media
• Microscopes
• 6.7. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-prepared IHC Kits
• Multiplex IHC Kits
• Specialty Kits

7. Immunohistochemistry (IHC) Market Regional And Country Analysis

• 7.1. Global Immunohistochemistry (IHC) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Immunohistochemistry (IHC) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunohistochemistry (IHC) Market

• 8.1. Asia-Pacific Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunohistochemistry (IHC) Market

• 9.1. China Immunohistochemistry (IHC) Market Overview
• 9.2. China Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunohistochemistry (IHC) Market

• 10.1. India Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunohistochemistry (IHC) Market

• 11.1. Japan Immunohistochemistry (IHC) Market Overview
• 11.2. Japan Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunohistochemistry (IHC) Market

• 12.1. Australia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunohistochemistry (IHC) Market

• 13.1. Indonesia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunohistochemistry (IHC) Market

• 14.1. South Korea Immunohistochemistry (IHC) Market Overview
• 14.2. South Korea Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunohistochemistry (IHC) Market

• 15.1. Western Europe Immunohistochemistry (IHC) Market Overview
• 15.2. Western Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunohistochemistry (IHC) Market

• 16.1. UK Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunohistochemistry (IHC) Market

• 17.1. Germany Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunohistochemistry (IHC) Market

• 18.1. France Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunohistochemistry (IHC) Market

• 19.1. Italy Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunohistochemistry (IHC) Market

• 20.1. Spain Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunohistochemistry (IHC) Market

• 21.1. Eastern Europe Immunohistochemistry (IHC) Market Overview
• 21.2. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunohistochemistry (IHC) Market

• 22.1. Russia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunohistochemistry (IHC) Market

• 23.1. North America Immunohistochemistry (IHC) Market Overview
• 23.2. North America Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunohistochemistry (IHC) Market

• 24.1. USA Immunohistochemistry (IHC) Market Overview
• 24.2. USA Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunohistochemistry (IHC) Market

• 25.1. Canada Immunohistochemistry (IHC) Market Overview
• 25.2. Canada Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunohistochemistry (IHC) Market

• 26.1. South America Immunohistochemistry (IHC) Market Overview
• 26.2. South America Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunohistochemistry (IHC) Market

• 27.1. Brazil Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunohistochemistry (IHC) Market

• 28.1. Middle East Immunohistochemistry (IHC) Market Overview
• 28.2. Middle East Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunohistochemistry (IHC) Market

• 29.1. Africa Immunohistochemistry (IHC) Market Overview
• 29.2. Africa Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunohistochemistry (IHC) Market Competitive Landscape And Company Profiles

• 30.1. Immunohistochemistry (IHC) Market Competitive Landscape
• 30.2. Immunohistochemistry (IHC) Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Immunohistochemistry (IHC) Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Cell Signaling Technology Inc.
• 31.3. Bio SB Inc.
• 31.4. Agilent Technologies Inc.
• 31.5. Abcam plc
• 31.6. Becton Dickinson and Company
• 31.7. Takara Bio Inc.
• 31.8. Biocare Medical LLC
• 31.9. Bio-Genex Laboratories
• 31.10. Diagnostic BioSystems Inc.
• 31.11. BioVision Inc.
• 31.12. PHC Holdings Corporation
• 31.13. Abbott Laboratories
• 31.14. Leica Biosystems
• 31.15. Vector Laboratories

32. Global Immunohistochemistry (IHC) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunohistochemistry (IHC) Market

34. Recent Developments In The Immunohistochemistry (IHC) Market

35. Immunohistochemistry (IHC) Market High Potential Countries, Segments and Strategies

• 35.1 Immunohistochemistry (IHC) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Immunohistochemistry (IHC) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Immunohistochemistry (IHC) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer